BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Biolytix AG to Offer Industrial Gene Expression Analysis and Genotyping Services Using Affymetrix (Santa Clara, California) (AFFX)' GeneChip(R) Technology


11/29/2007 10:59:08 AM

WITTERSWIL, Switzerland, November 29 /PRNewswire/ -- Biolytix AG (http://www.biolytix.ch) signed a service provider agreement with Affymetrix UK Ltd (http://www.affymetrix.com) and offers genomic analysis services for the academic and industrial R&D community under conditions compliant with a stringent quality management system.

Biolytix, one of the leading CRO's for molecular biological analysis in Switzerland has acquired a complete Affymetrix GeneChip(R) instrument system to enhance the range of services offered. Besides standard gene expression analysis services, with this state-of-the-art equipment Biolytix is ready to offer services using the latest generation GeneChip(R) products. These include Exon and Tiling arrays as well as SNP genotyping and gene mapping arrays with potential applications in transcriptome mapping, the analysis of gene regulation as well as genome wide SNP mapping and re-sequencing using standard and custom arrays.

The appointment of Biolytix as an Affymetrix authorized service provider further enhances the strong reputation of the company in the molecular biology service provider community. Current and future customers of Biolytix worldwide have now access to the offerings of Affymetrix via the services provided by the company.

Biolytix AG, specialized in molecular and microbiological analyses, was founded in 1998 and is situated in Witterswil (Switzerland), 12 km south-west of Basel. The team and its scope of activities have been expanding continuously. Biolytix, accredited according to ISO/IEC 17025, offers a wide range of services, the major ambition being to fulfil the customers' expectations through confidential and responsible cooperation. The fields of activity of Biolytix are widely distributed in the pharmaceutical, food and cosmetic industry as well as in the veterinarian, agricultural and human diagnostics.

adrian.haerri@biolytix.ch

CONTACT: Adrian Harri, CEO, adrian.haerri@biolytix.ch, Biolytix AG,
Benkenstrasse 254, CH-4108 Witterswil, Switzerland, Tel. +41(0)61-7252070,
Fax. +41(0)61-7252071



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES